Insulin resistance - Its causes and therapy possibilities;Inzulinová resistance - příčiny a možnosti ovlivnění

Vnitrni Lekarstvi

Volumn 60, Issue 9, 2014, Pages 746-755

  Pelikáinovcá, Terezie ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Cytokines; Insulin resistance; Insulin signalling cascade

Indexed keywords

CORTICOSTEROID; INSULIN; MESSENGER RNA; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PIOGLITAZONE;

ARTICLE; CELL STRUCTURE; GLUCOSE METABOLISM; HYPERINSULINEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; SIGNAL TRANSDUCTION; WEIGHT REDUCTION;

EID: 84908460863     PISSN: 0042773X     EISSN: 18017592     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kurland U, Accili 0, Burant C et al. Application of combined omics platforms to accelerate biomedical discovery in diabesity. Ann NY Acad Scl 2013; 1287:1-16.
2. Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol 2014; 220(2): T1-T23.
3. Saltiel AR. Putting the brakes on insulin signaling. N Engl J Med 2003; 349(26): 2560-2562.
4. Grarup N, Sandholt CH, Hansen T et al. Genetic susceptibility to type 2 diabetes and obesity, from genome-wide association studies to rare variants and beyond. Diabetologia 2014; 57:1528-1541.
5. Ahlqvist E, Ahluwalia TS, Groop L. Genetics of type 2 diabetes. Clin Chem 2011; 57(2): 241-254.
6. Sookoian S, Pirola CI. Epigenetics of Insulin resistance: Fn emerging field in translational medicine. Curr Diab Rep 2013; 13(2): 229-237.
7. Raltoharju E, Seppala I, Oksala N et al. Blood microRNA profile associates with the levels of serum lipids and metabolites associated with glucose metabolism and insulin resistance and pinpoints pathways underlying metabolic syndrome: The cardiovascular risk in Young Finns Study. Mol Cell Endocrinol 2014; 391(1-2): 41-49.
8. Chen H, Lan HY, Roukos DH et al. Application of microrn As In diabetes mellitus. J Endocrinol 2014; 222(1): R1-R10.
9. Mohamed JS, Hajira A, Pardo PS et al.MicroRNA-149 Inhibits PARP-2 and promotes mitochondrial biogenesis via SIRT-1/PGC-1alpha network in skeletal muscle. Diabetes 2014; 63(5): 1546-1559.
10. Svensson K, Handschln C. MicroRNAs emerge as modulators of NAD-f-dependent energy metabolism in skeletal muscle. Diabetes 2014; 63(5): 1451-1453.
11. Škrha J. Biochemickél dusledky dlouhodobé hyperglyké-mle. In: Škrha J (ed). Dlabetologie. Galéln: Praha 2009: 66-75. ISBN 978-80-7262-607-6.
12. Evans JL, Goldfine ID, Maddux BA et al. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003; 52(1): 1-8.
13. Randle PJ, Garland PB, Hales CN et al. The glucose fatty-add cycle. Its role in Insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1(7285): 785-789.
14. Unger RH, dark GO, Scherer PE et al. Lipid homeostasis, lipotoxkRy and the metabolic syndrome. Biochim Biophys Acta 2010; 1801(3): 209-214.
15. Krusinova E, Pelikanova T. Fatty acid binding proteins in adipose tissue: F promising link between metabolic syndrome and atherosclerosis? Diabetes Res Clin Pract 2008; 82(Suppl 2): S127-S134.
16. Ruderman NB, Carting D, Prentki M et al. AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest 2013; 123(7): 2764-2772.
17. Larsen PJ, Tennagels N. On ceramides, other sphingolipids and Impaired glucose homeostasis. Mol Metab 2014; 3(3): 252-260.
18. Masi LN, Rodrigues AC, Curl R. Fatty acids regulation of inflammatory and metabolic genes. Curr Opln Clin Nutr Metab Care 2013; 16(4): 418-424.
19. Pelikanova T, Kohout M, Valek J et al. Insulin secretion and insulin action related to the serum phospholipid fatty add pattern in healthy men. Metabolism 1989; 38(2): 188-192.
20. Pelikanova T, Kohout M, Hilgertova J et al. Erythrocyte Insulin receptor characteristics and erythrocyte membrane lipid composition in healthy men. Physiol Bohemoslov 1989; 38(5): 419-425.
21. Storlien LH, Jenkins AB, Chisholm DJ et al. Influence of dietary fat composition on development of insulin resistance In rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991; 40(2): 280-289.
22. Borkman M, Storlien LH, Pan DA et al. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 1993; 328(4): 238-244.
23. Pelikanova T, Kazdova L, Chvojkova S et al. Serum phospholipid fatty acid composition and Insulin action In type 2 diabetic patients. Metabolism 2001; 50(12): 1472-1478.
24. Suchankova G, Vlasakova Z, Zicha J et al. Effect of acute hyperglycemia on erythrocyte membrane ion transport in offspring of hypertensive parents. J Hypertens 2003; 21(7): 1325-1330.
25. Kahleova H, Matoulek M, Bratova M et al. Vegetarian diet-Induced Increase In linoleic acid in serum phospholipids is associated with improved insulin sensitivity in subjects with type 2 diabetes. Nutr Diabetes 2007; 3: e75. Dostupne w DOI: .
26. Kahleova H, Belinova L, Malinska H et al. Eating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reduced-energy regimen for patients with type 2 diabetes: F randomised crossover study. Diabetologia 2014; 57(8): 1552-1560.
27. Bluher M. Adipokines - removing road blocks to obesity and diabetes therapy. Mol Metab 2014; 3(3): 230-240.
28. Eckardt K, Gorgens SW, Raschke S et al. Myokines in insulin resistance and type 2 diabetes. Diabetologia 2014; 57 (6): 1087-1099.
29. Chatzigeorgiou A, Karalis KP, Bornstein SR et al. Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia 2012; 55(10): 2583-2592.
30. Hocking S, Samocha-Bonet D, Milner KL et al. Adiposity and insulin resistance in humans: The role of the different tissue and cellular lipid depots. Endocr Rev 2013; 34(4): 463-500.
31. Duarte AL, Candelas E, Correia SC et al. Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetlcs as a promising therapy against neurodegeneration. Blochtm Biophys Acta 2013; 1832(4): 527-541.
32. Cani PD, Everard A, Duparc T. Gut microbiota, enteroendocrlne functions and metabolism. Curr Opin Pharmacol 2013; 13(6): 935-940.
33. Hong SH, Ahmadlan M, Yu RT et al. Nuclear receptors and metabolism: from feast to famine. Diabetologia 2014; 57(5): 860-867.
34. Bass J. Orcadian topology of metabolism. Nature 2012; 491 (7424): 348-356.
35. Novak J, Blenertova-Vasku J, Slaby O. MikroRNA a diabetes melli-Tus. In: Kvapil M (ed). Diabetologie 2014. Triton: Praha 2014:225-233. ISBN 978-80-7387-755-2.
36. Ridker PM, Howard CP, Walter V et al. Effects of interieukin-1beta Inhibition with canakinumab on hemoglobin Ale, lipids, C-reactive protein, lnterleukin-6, and fibrinogen: F phase lib randomized, placebo-controlled trial. Circulation 2012; 126(23): 2739-2748